Metabolism of the Insecticide Permethrin
Information source: University of California, Davis
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pharmacokinetics; Metabolism
Intervention: permethrin insecticide (Other)
Phase: N/A
Status: Completed
Sponsored by: University of California, Davis Official(s) and/or principal investigator(s): Bruce D Hammock, PhD, Principal Investigator, Affiliation: University of California, Davis
Summary
Military personnel are exposed to the insecticide permethrin when using the DOD Insect
Repellent System. A urinary metabolite of permethrin that is in high abundance and is
relatively stable may be an ideal biomarker of exposure to this pesticide. Monitoring such a
biomarker can prevent over-exposure. The objectives are to identify the most abundant human
urinary metabolite following dermal exposure; to utilize this information to develop rapid
laboratory-based and field portable methods to monitor the degree of an individual's exposure
to permethrin.
Clinical Details
Official title: CCRC:Identification and Development of Biological Markers of Human Exposure to the Insecticide Permethrin
Study design: Basic Science, Open Label, Single Group Assignment, Pharmacokinetics Study
Primary outcome: Concentration of individual metabolites in urine
Secondary outcome: total carbon-14 in serumTotal carbon-14 in saliva Total carbon-14 in urine samples
Detailed description:
Permethrin is applied to the forearm of the subject and remains for 8 hours. The exposed area
is then washed with soap and water several times. 24 hour urine samples are collected at
daily intervals for 192 hours. Blood and saliva samples are taken at pre-dose, 1, 3, 6, 9 12,
24, 48, 72, 96, 120, 144, 168 and 192 hours. Subjects must return to the clinic daily to drop
off urine collections and have blood and saliva samples taken.
Eligibility
Minimum age: 18 Years.
Maximum age: 50 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- self-report healthy adult men and premenopausal women
Exclusion Criteria:
- unusual alcohol, drug, cigarette use for last 3 years
- unusual exercise program for last 3 years
- under the care of a physician for a disease
- participated in any radioactive drug study
- pregnant
- lactating
- people who rely more on their arm due to illness or injury
- people with neurological or musculoskeletal diseases
- use of permethrin in the last 6 months
- people who apply pesticides as their primary occupation
Locations and Contacts
CTSC Research Center, Mather, California 95655, United States
Additional Information
Starting date: February 2006
Ending date: November 2007
Last updated: December 11, 2007
|